Larry Biegelsen is ranked #816 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Larry Biegelsen

Larry Biegelsen

Q: How accurate are Larry Biegelsen's stock ratings?

About 55% of Larry's ratings were profitable over a one-year hold, with an average return of +3.3% per rating, measured by 13Foresight from historical prices.

Wells Fargo

Wall Street Analyst

★★★★☆

#816

on 13Foresight · ranked by our own returns

54%

Success Rate

+2.5%

Average Return

75 of 138 calls profitable · +0.9% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 54% of Larry Biegelsen's ratings turned a profit when each position was held for 2 year — averaging +2.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

139 Buy 61 Hold 0 Sell

Larry's Stock Coverage 43 ratings · 2026-11-08

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	2-Yr Return	vs S&P 500 ⓘ
NVCR NovoCure	Oct 30, 2026	HOLD	Strong Buy +273.4% avg upside 11 analysts	$15.00 14.13% Upside	+1.0%	·
CNMD Conmed	Oct 29, 2026	HOLD	Hold +48.7% avg upside 12 analysts	$49.00 10.67% Upside	-3.1%	·
BBNX Beta Bionics, Inc.	Oct 28, 2026	BUY	Strong Buy +45.7% avg upside 17 analysts	$28.00 67.09% Upside	-5.0%	·
ABT Abbott Laboratories	Oct 23, 2026	BUY	Strong Buy +8.6% avg upside 36 analysts	$120.00 13.08% Upside	+6.0%	·
IART Integra Lifesciences	Oct 22, 2026	HOLD	Buy +208.0% avg upside 22 analysts	$13.00 1.89% Upside	+3.4%	·
ISRG Intuitive Surgical	Oct 21, 2026	BUY	Strong Buy +12.0% avg upside 37 analysts	$486.00 12.40% Upside	+5.8%	·
JNJ Johnson & Johnson	Oct 15, 2026	BUY	Strong Buy -9.1% avg upside 40 analysts	$287.00 4.96% Upside	+9.1%	·
KMTS Kestra Medical Technologies Ltd.	Oct 15, 2026	BUY	Strong Buy -4.9% avg upside 9 analysts	$28.00 5.69% Downside	-0.5%	·
DXCM Dexcom	Oct 14, 2026	BUY	Strong Buy +31.4% avg upside 33 analysts	$90.00 9.38% Upside	-3.0%	·
AXGN AxoGen	Oct 02, 2026	BUY	Strong Buy -17.4% avg upside 21 analysts	$48.00 2.75% Downside	+30.4%	·
BSX Boston Scientific	Sep 24, 2026	HOLD	Strong Buy +43.0% avg upside 38 analysts	$48.00 14.32% Upside	-4.3%	·
CH:ALC Alcon	Sep 18, 2026	BUY	Strong Buy +19.4% avg upside 36 analysts	$70.58 19.52% Upside	+10.4%	·
BLCO Bausch + Lomb Corporation	Sep 18, 2026	HOLD	Buy +7.6% avg upside 20 analysts	$18.00 10.02% Downside	+18.2%	·
SYK Stryker	Sep 16, 2026	BUY	Strong Buy +18.5% avg upside 38 analysts	$348.00 19.18% Upside	+14.8%	·
MDT Medtronic	Sep 09, 2026	BUY	Buy +4.4% avg upside 38 analysts	$104.00 7.69% Upside	+11.7%	·
COO Cooper Co	Sep 09, 2026	HOLD	Buy +105.8% avg upside 21 analysts	$61.00 2.35% Upside	+0.1%	·
ENOV Enovis	Sep 08, 2026	BUY	Strong Buy +226.7% avg upside 39 analysts	$33.00 65.71% Upside	+21.1%	·
MMED MiniMed Group, Inc.	Sep 08, 2026	BUY	Strong Buy +37.7% avg upside 17 analysts	$26.00 42.22% Upside	-21.6%	·
GEHC GE Healthcare Technologies Inc	Aug 25, 2026	BUY	Strong Buy +10.3% avg upside 23 analysts	$85.00 11.02% Upside	+11.5%	·
HTFL HeartFlow, Inc.	Aug 14, 2026	BUY	Strong Buy -24.3% avg upside 10 analysts	$39.00 33.88% Downside	+24.5%	·
AVR Anteris Technologies Global Corp.	Aug 13, 2026	BUY	Strong Buy +131.4% avg upside 5 analysts	$16.00 153.50% Upside	-36.6%	·
NPCE NeuroPace	Aug 12, 2026	BUY	Strong Buy +46.9% avg upside 14 analysts	$19.00 54.57% Upside	-15.5%	·
GMED Globus Medical	Aug 07, 2026	BUY	Strong Buy +18.9% avg upside 24 analysts	$99.00 26.91% Upside	-13.7%	·
RXST RxSight	Aug 06, 2026	HOLD	Hold +86.0% avg upside 13 analysts	$9.00 84.85% Upside	-19.9%	·
ZBH Zimmer Biomet Holdings	Aug 06, 2026	HOLD	Buy +20.5% avg upside 39 analysts	$103.00 9.02% Upside	+8.9%	·
PODD Insulet	Aug 05, 2026	HOLD	Strong Buy +40.0% avg upside 32 analysts	$144.00 3.86% Downside	+23.8%	·
ATEC Alphatec Holdings	Aug 05, 2026	BUY	Strong Buy +117.0% avg upside 23 analysts	$14.00 98.91% Upside	-22.3%	·
INSP Inspire Medical Systems	Aug 04, 2026	HOLD	Buy +30.5% avg upside 21 analysts	$56.00 17.75% Downside	-3.5%	·
PEN Penumbra	Aug 03, 2026	HOLD	Buy +3.6% avg upside 23 analysts	$374.00 17.26% Upside	-1.2%	·
MMSI Merit Medical Systems	Jul 31, 2026	HOLD	Strong Buy +15.6% avg upside 16 analysts	$83.00 3.67% Downside	-0.8%	·
GKOS Glaukos	Jul 30, 2026	BUY	Strong Buy -18.6% avg upside 21 analysts	$178.00 25.14% Downside	+33.2%	·
TNDM Tandem Diabetes Care	Jun 01, 2026	BUY	Buy +64.3% avg upside 29 analysts	$27.00 41.24% Upside	-5.0%	·
SOLV Solventum Corporation	May 22, 2026	HOLD	Buy +12.8% avg upside 16 analysts	$70.00 13.98% Downside	+18.7%	·
TFX Teleflex	May 08, 2026	HOLD	Buy +31.3% avg upside 20 analysts	$138.00 1.28% Downside	+13.2%	·
ITGR Integer Holdings	Feb 20, 2026	HOLD	Buy -18.9% avg upside 16 analysts	$84.00 33.61% Downside	+49.2%	·
EW Edwards Lifesciences	Feb 11, 2026	BUY	Strong Buy +10.0% avg upside 35 analysts	$100.00 8.76% Upside	+27.7%	·
BDX Becton Dickinson	Feb 10, 2026	HOLD	Buy -0.4% avg upside 25 analysts	$157.00 20.56% Downside	+24.2%	·
RMD Resmed	Jan 30, 2026	HOLD	Buy +4.7% avg upside 27 analysts	$270.00 17.52% Upside	-6.1%	·
BAX Baxter International	Dec 12, 2025	HOLD	Buy +45.2% avg upside 23 analysts	$19.00 17.31% Downside	+33.3%	·
LUNG Pulmonx	Nov 13, 2025	HOLD	Buy +152.2% avg upside 9 analysts	$3.00 0.17% Downside	+89.0%	·
HYPR Hyperfine	Oct 21, 2025	HOLD	Strong Buy +174.2% avg upside 7 analysts	—	-43.8%	·
LNTH Lantheus	Aug 02, 2018	BUY	Buy -19.7% avg upside 21 analysts	$20.00 80.13% Downside	+1.0%	·
NVS Novartis	Jan 04, 2010	BUY	Hold -16.1% avg upside 24 analysts	—	+19.1%	·

🔒 38 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Larry Biegelsen — Frequently Asked Questions

How accurate are Larry Biegelsen's stock ratings?

Based on the calls 13Foresight could measure, about 55% of Larry's ratings were profitable over a one-year hold, with an average return of +3.3% per rating, or +1.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Larry ranked on 13Foresight?

Larry Biegelsen is currently ranked #816 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Larry cover?

Larry most recently has ratings on NVCR, CNMD, BBNX, ABT, IART, ISRG, JNJ, KMTS, DXCM, AXGN, BSX, CH:ALC and 31 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Larry Biegelsen

Rating Distribution

Welcome to 13Foresight!